Cargando…
ITGB4 is a novel prognostic factor in colon cancer
Integrin β4 (ITGB4) has been reported to be involved in carcinomas. Currently, ITGB4 has been characterized in colon cancer, however, its clinical significance is not very clear. In the present study, we utilized the large public datasets from NCBI Gene Expression Omnibus (GEO) and The Cancer Genome...
Autores principales: | Li, Meng, Jiang, Xia, Wang, Guiqi, Zhai, Congjie, Liu, Ying, Li, Hongyan, Zhang, Yan, Yu, Weifang, Zhao, Zengren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775604/ https://www.ncbi.nlm.nih.gov/pubmed/31602273 http://dx.doi.org/10.7150/jca.29269 |
Ejemplares similares
-
ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
por: Jiang, Xia, et al.
Publicado: (2021) -
TRIM67 inhibits tumor proliferation and metastasis by mediating MAPK11 in Colorectal Cancer
por: Liu, Ying, et al.
Publicado: (2020) -
Cyto-biological effects of microRNA-424-5p on human colorectal cancer cells
por: Yan, Weitao, et al.
Publicado: (2020) -
Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1
por: Jiang, Xia, et al.
Publicado: (2020) -
Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer
por: He, Yuzheng, et al.
Publicado: (2017)